Neurotech International Ltd.ASX: NTI

Commencement of Phase II/III ASD Clinical Trial

Dec 19, 2022 at 7:25 AM UTC · Issued by Neurotech International Ltd.

Neurotech International Ltd has released a press release.

View Attachment